302 related articles for article (PubMed ID: 31932215)
1. Lipocalin-2 expression and function in pancreatic diseases.
Gumpper K; Dangel AW; Pita-Grisanti V; Krishna SG; Lara LF; Mace T; Papachristou GI; Conwell DL; Hart PA; Cruz-Monserrate Z
Pancreatology; 2020 Apr; 20(3):419-424. PubMed ID: 31932215
[TBL] [Abstract][Full Text] [Related]
2. Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types.
Rahimi S; Roushandeh AM; Ahmadzadeh E; Jahanian-Najafabadi A; Roudkenar MH
Mol Biol Rep; 2020 Mar; 47(3):2327-2346. PubMed ID: 31970626
[TBL] [Abstract][Full Text] [Related]
3. Loss of the adipokine lipocalin-2 impairs satellite cell activation and skeletal muscle regeneration.
Rebalka IA; Monaco CMF; Varah NE; Berger T; D'souza DM; Zhou S; Mak TW; Hawke TJ
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C714-C721. PubMed ID: 30257107
[TBL] [Abstract][Full Text] [Related]
4. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
Gomez-Chou SB; Swidnicka-Siergiejko AK; Badi N; Chavez-Tomar M; Lesinski GB; Bekaii-Saab T; Farren MR; Mace TA; Schmidt C; Liu Y; Deng D; Hwang RF; Zhou L; Moore T; Chatterjee D; Wang H; Leng X; Arlinghaus RB; Logsdon CD; Cruz-Monserrate Z
Cancer Res; 2017 May; 77(10):2647-2660. PubMed ID: 28249896
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis.
Jung BK; Ryu KY
Exp Mol Med; 2023 Oct; 55(10):2138-2146. PubMed ID: 37779143
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.
Asaf S; Maqsood F; Jalil J; Sarfraz Z; Sarfraz A; Mustafa S; Ojeda IC
Immunol Res; 2023 Jun; 71(3):287-313. PubMed ID: 36529828
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway.
Hao P; Zhang J; Fang S; Jia M; Xian X; Yan S; Wang Y; Ren Q; Yue F; Cui H
Hum Cell; 2022 Sep; 35(5):1475-1486. PubMed ID: 35792978
[TBL] [Abstract][Full Text] [Related]
8. Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure.
Marques FZ; Prestes PR; Byars SG; Ritchie SC; Würtz P; Patel SK; Booth SA; Rana I; Minoda Y; Berzins SP; Curl CL; Bell JR; Wai B; Srivastava PM; Kangas AJ; Soininen P; Ruohonen S; Kähönen M; Lehtimäki T; Raitoharju E; Havulinna A; Perola M; Raitakari O; Salomaa V; Ala-Korpela M; Kettunen J; McGlynn M; Kelly J; Wlodek ME; Lewandowski PA; Delbridge LM; Burrell LM; Inouye M; Harrap SB; Charchar FJ
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28615213
[TBL] [Abstract][Full Text] [Related]
9. Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and neutrophil extracellular traps.
Li H; Feng D; Cai Y; Liu Y; Xu M; Xiang X; Zhou Z; Xia Q; Kaplan MJ; Kong X; Gao B
Hepatology; 2018 Oct; 68(4):1604-1620. PubMed ID: 29633303
[TBL] [Abstract][Full Text] [Related]
10. LCN2-interacting proteins and their expression patterns in brain tumors.
Du Z; Wu B; Xia Q; Zhao Y; Lin L; Cai Z; Wang S; Li E; Xu L; Li Y; Xu H; Yin D
Brain Res; 2019 Oct; 1720():146304. PubMed ID: 31233712
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin-2 is an anorexigenic signal in primates.
Petropoulou PI; Mosialou I; Shikhel S; Hao L; Panitsas K; Bisikirska B; Luo N; Bahna F; Kim J; Carberry P; Zanderigo F; Simpson N; Bakalian M; Kassir S; Shapiro L; Underwood MD; May CM; Soligapuram Sai KK; Jorgensen MJ; Confavreux CB; Shapses S; Laferrère B; Mintz A; Mann JJ; Rubin M; Kousteni S
Elife; 2020 Nov; 9():. PubMed ID: 33231171
[TBL] [Abstract][Full Text] [Related]
12. E74-like factor 3 and nuclear factor-κB regulate lipocalin-2 expression in chondrocytes.
Conde J; Otero M; Scotece M; Abella V; López V; Pino J; Gómez R; Lago F; Goldring MB; Gualillo O
J Physiol; 2016 Nov; 594(21):6133-6146. PubMed ID: 27222093
[TBL] [Abstract][Full Text] [Related]
13. Overview of the expression patterns and roles of Lipocalin 2 in the reproductive system.
Krizanac M; Mass Sanchez PB; Weiskirchen R; Schröder SK
Front Endocrinol (Lausanne); 2024; 15():1365602. PubMed ID: 38645429
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.
Kurozumi S; Alsaeed S; Orah N; Miligy IM; Joseph C; Aljohani A; Toss MS; Fujii T; Shirabe K; Green AR; Aleskandarany MA; Rakha EA
Breast Cancer Res Treat; 2020 Feb; 179(3):557-564. PubMed ID: 31707510
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 as a therapeutic target for brain injury: An astrocentric perspective.
Suk K
Prog Neurobiol; 2016 Sep; 144():158-72. PubMed ID: 27498195
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice.
Ponzetti M; Aielli F; Ucci A; Cappariello A; Lombardi G; Teti A; Rucci N
J Cell Physiol; 2022 Jan; 237(1):551-565. PubMed ID: 34224151
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages.
Toyonaga T; Matsuura M; Mori K; Honzawa Y; Minami N; Yamada S; Kobayashi T; Hibi T; Nakase H
Sci Rep; 2016 Oct; 6():35014. PubMed ID: 27734904
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin-2 Upregulation in Nasopharyngeal Carcinoma: A Novel Potential Diagnostic Biomarker.
Jani Kargar Moghaddam S; Mohammadi Roushandeh A; Hamidi M; Nemati S; Jahanian-Najafabadi A; Habibi Roudkenar M
Iran J Med Sci; 2023 May; 48(3):268-276. PubMed ID: 37791335
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2 mediates the rejection of neural transplants.
Weng YC; Huang YT; Chiang IC; Tsai PJ; Su YW; Chou WH
FASEB J; 2021 Feb; 35(2):e21317. PubMed ID: 33421207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
